Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-027507

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kunkel Lori Anne · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-04 Grant or award : show line 1 in the form Director Stock Option (right to buy) +25,000 25,000 D
Loading xslF345X04/doc4.xml…